In vitro evaluation of novel antibiotics against Pseudomonas aeruginosa infection on Human Airway Epithelia


The SupAir project: A long term culture of nasal-tracheal-bronchial and bronchiolar human airway epithelia at interconnected and dynamic liquid flow conditions


Respiratory irritants cause reversible up-regulation of pro-inflammatory cytokines on human nasal mucosa reconstituted in vitro


Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro


Efficient replication of respiratory syncytal virus induces a decrease of mucociliary clearance in human small airway 3D culture


Efficacy of antiviral drugs in a human in vitro nasal epithelium model (MucilAir™)


Establishment and Characterization of an in vitro Human Small Airway Model (SmallAir™)


Airway epithelium co-cultured with immune cells for a better assessment of the low dose effects of environmental pollutants


Evaluation of reconstituted human bronchial epithelium (MucilAir™) suitability for repeated dose testing


Development of a human airway tissue-based assay for respiratory absorption giving input parameters for PBTK modelling


Toxicity assessment of construction materials in vitro on Human 3D Airway Epithelium (MucilAir™) using highly sensitive functional endpoints


Goblet cell metaplasia induced in a fully differentiated human airway epithelium (MucilAir ™)


Development of an in vitro assay for assessing the anti-inflammatory drug effects based on human airway epithelium


The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV)




A simple method for testing the toxicity of nanomaterials on 3D Air-Liquid Interface Human Airway Epithelia (MucilAir™)


An in vitro testing strategy for the development of novel inhaled therapeutics using Human 3D Airway Epithelium Model (MucilAir™)


Comparison of respiratory virus infection between human nasal epithelial cell monolayer and air-liquid interface 3D culture


Evaluation of a human in vitro 3D respiratory epitheli um model in bioavaila bility and safety assessment of pharmaceutical and chemical compounds


Smoke Inhalation – Decontamination Study of Toxic Substances on an in vitro Model of Human Airway Epithelium


Development of a new 3D-Human Airway Epithelium/ Whole-blood Co-culture Model Combined with Multi-Analyte Profile (MAP) Analyses for Assessing Drug Effects


MucilAir™ versus RAW 264.7 cells in nanotoxicology


Human 3D airway models to predict in vivo bioavailability upon inhalation

Needs more posters, information or reprint, Please contact us at